DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,731 Cr | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr | ₹1,677 Cr |
What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹2,731 Cr |
| Mar2024 | ₹2,156 Cr |
| Mar2023 | ₹1,793 Cr |
| Mar2022 | ₹2,424 Cr |
| Mar2021 | ₹1,677 Cr |
How is Sundry Debtors of DIVIS LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,731 Cr | 26.67 | |
| Mar2024 | ₹2,156 Cr | 20.25 | |
| Mar2023 | ₹1,793 Cr | -26.03 | |
| Mar2022 | ₹2,424 Cr | 44.58 | |
| Mar2021 | ₹1,677 Cr | - | |
Compare Sundry Debtors of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹177,200.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,048.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,804.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,642.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,368.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
| MANKIND PHARMA | ₹102,729.0 Cr | 0.6% | 7.3% | 10.3% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -3.1% |
-0.1% |
0.2% |
| SENSEX | 0.7% |
4.4% |
-5.6% |
You may also like the below Video Courses